MODALIM

This brand name is authorized in Netherlands, Singapore, United Kingdom

Active ingredients

The drug MODALIM contains one active pharmaceutical ingredient (API):

1 Ciprofibrate UNII F8252JGO9S - CIPROFIBRATE

Ciprofibrate is a new derivative of phenoxyisobutyric acid which has a marked hypolipidaemic action. It reduces both LDL and VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol. Read about Ciprofibrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MODALIM Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AB08	Ciprofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates
Discover more medicines within C10AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50377
Country: SG	Health Sciences Authority	Identifier(s): 08383P